Role of phase 0 trials in drug development

James H. Doroshow, Shivaani Kummar

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations

Abstract

Phase 0 trials can provide proof of concept that an agent modulates its intended target without exposing patients to the drug-tolerability testing that precedes efficacy evaluation. Drugs that do not modulate their targets can be discarded, focusing development resources on the most clinically promising agents. However, wider uptake of Phase 0 trials may be hindered by ethical concerns over their lack of therapeutic intent, the substantial resources required to develop and validate target assays or skepticism that such trials save development time.

Original languageEnglish (US)
Pages (from-to)1375-1380
Number of pages6
JournalFuture Medicinal Chemistry
Volume1
Issue number8
DOIs
StatePublished - Nov 2009
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Role of phase 0 trials in drug development'. Together they form a unique fingerprint.

Cite this